文献速递乳房整形与再造

荷兰与美国即刻乳房再造的国际医疗质量比较概念验证研究

Immediate Breast Reconstruction in The Netherlands and the United States: A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

该概念验证研究比较了荷兰NBCA(2011-2015)与美国SEER(2010-2013)两个癌症登记数据库的结构与内容,并以乳房切除后即刻乳房再造率作为概念验证指标。结果显示NBCA治疗特异性变量更多,SEER癌症特异性变量更多;两组数据中即刻乳房再造率均随时间显著上升。作者倡导建立变量对齐的国际数据库以改善全球乳腺癌诊疗质量。

要点

  • NBCA治疗特异性变量显著多于SEER(46 vs 6),SEER癌症特异性变量更多(74 vs 26)。
  • 乳腺癌患者即刻乳房再造率:NBCA 19.3%,SEER 24.0%;DCIS患者:NBCA 44.0%,SEER 35.3%。
  • 两个数据库中即刻乳房再造率均随时间显著增加。

核心结论

  • 该研究首次概览了荷兰与美国乳腺癌诊疗登记数据,揭示美国治疗相关数据有限。
  • 即刻乳房再造治疗模式的比较显示两国存在值得关注的差异。
  • 作者倡导建立变量对齐的国际数据库以提升全球乳腺癌诊疗质量。

研究设计与样本

  • 概念验证研究,比较荷兰NBCA(2011-2015)与美国SEER(2010-2013)两个现有登记数据库的结构与内容。
  • 将数据变量分为一般、治疗特异性、癌症特异性和随访变量并进行匹配。
  • 以浸润性乳腺癌或导管原位癌患者的乳房切除与即刻乳房再造率作为概念验证分析。

主要发现

  • NBCA包含115个变量,SEER包含112个变量。
  • NBCA治疗特异性变量显著更多(n=46 vs 6),SEER癌症特异性变量更多(n=74 vs 26)。
  • 乳腺癌队列中即刻乳房再造率NBCA为19.3%,SEER为24.0%。
  • DCIS队列中即刻乳房再造率NBCA为44.0%,SEER为35.3%。
  • 两个数据集中即刻乳房再造率均随时间显著增加。

临床怎么用

  • 提示跨国数据库比较需注意变量结构与治疗特异性数据的差异。
  • 美国SEER数据库治疗相关数据有限,解读其再造率时需谨慎。
  • 可为后续建立变量对齐的国际乳腺癌登记数据库提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies based on large-volume databases have made significant contributions to research on breast cancer surgery. To date, no comparison between large-volume databases has been made internationally. This is the first proof-of-concept study exploring the feasibility of combining two existing operational databases of The Netherlands and the United States, focusing on breast cancer care and immediate breast reconstruction specifically.313/291 METHODS:: The National Breast Cancer Organization The Netherlands Breast Cancer Audit (NBCA) (2011 to 2015) and the U.S. Surveillance, Epidemiology, and End Results (SEER) database (2010 to 2013) were compared on structure and content. Data variables were grouped into general, treatment-specific, cancer-specific, and follow-up variables and were matched. As proof-of-concept, mastectomy and immediate breast reconstruction rates in patients diagnosed with invasive breast cancer or ductal carcinoma in situ were analyzed. RESULTS: The NBCA included 115 variables and SEER included 112. The NBCA included significantly more treatment-specific variables (n = 46 versus 6), whereas the SEER database included more cancer-specific variables (n = 74 versus 26). In patients diagnosed with breast cancer or ductal carcinoma in situ, immediate breast reconstruction was performed in 19.3 percent and 24.0 percent of the breast cancer cohort and 44.0 percent and 35.3 percent of the ductal carcinoma in situ cohort in the NBCA and SEER, respectively. Immediate breast reconstruction rates increased significantly over time in both data sets. CONCLUSIONS: This study provides a first overview of available registry data on breast cancer care in The Netherlands and the United States, and revealed limited data on treatment in the United States. Comparison of treatment patterns of immediate breast reconstruction showed interesting differences. The authors advocate the urgency for an international database with alignment of (treatment) variables to improve quality of breast cancer care for patients across the globe.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Kamali P, van Bommel A, Becherer B, et al. Immediate Breast Reconstruction in The Netherlands and the United States: A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data. Plast Reconstr Surg. 2019. PMID: 31568284. doi:10.1097/PRS.0000000000006011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。